For the Inventor, By the Inventor

Enter assignee name

Corvallis, OR, United States of America

Siga Technologies Inc.

USPTO Granted Patents = 57

CIPO Patents = 6

EPO Patents = 12

Trademarks = 6

Forward Citations = 244

Loading Chart...

Loading Chart...

36 inventors (with patents filed for the assignee):

Dennis E Hruby (43 out of 52 patents)

Dongcheng Dai (33 out of 50 patents)

Tove C Bolken (20 out of 24 patents)

4. Shanthakumar R Tyavanagimatt (19 out of 19 patents)

5. Sean M Amberg (13 out of 19 patents)

6. Robert Jordan (13 out of 25 patents)

7. Thomas R Bailey (13 out of 54 patents)

8. William C Weimers (12 out of 12 patents)

9. Melialani A C L S Anderson (10 out of 10 patents)

10. N K Peter Samuel (9 out of 10 patents)

11. Susan R Rippin (8 out of 30 patents)

12. Dylan Nelson (7 out of 7 patents)

13. Michael H O'Neill (7 out of 10 patents)

14. Gary Sweetapple (7 out of 7 patents)

15. Kelley A McCloughan (7 out of 7 patents)

Core Competencies:

Polymorphic Forms

ST-246

Tecovirimat

Liquid Formulations

Micronized Tecovirimat

Antiviral Drugs

Dengue Infection

Arenavirus Infection

Amorphous Tecovirimat

Bacterial Pathogens

Viral Pathogens

Orthopoxvirus Infections

57 patents: Sort by Forward Citations

1. 12433868 - Polymorphic forms of ST-246 and methods of preparation (2025-10-07),

2. 11890270 - Polymorphic forms of ST-246 and methods of preparation (2024-02-06),

3. 11779566 - ST-246 (tecovirimat monohydrate) suspension formulations (2023-10-10),

4. 11433051 - ST-246 (tecovirimat monohydrate) suspension formulations (2022-09-06),

5. 10933050 - Polymorphic forms of ST-246 and methods of preparation (2021-03-02),

6. 10864282 - ST-246 liquid formulations and methods (2020-12-15),

7. 10716759 - Rehydration of micronized tecovirimat monohydrate (2020-07-21),

8. 10662155 - Methods of preparing tecovirimat (2020-05-26),

9. 10576165 - ST-246 liquid formulations and methods (2020-03-03),

10. 10406137 - Polymorphic forms of ST-246 and methods of preparation (2019-09-10),

11. 10406103 - Rehydration of micronized tecovirmimat monohydrate (2019-09-10),

12. 10155723 - Methods of preparing tecovirimat (2018-12-18),

13. 10124071 - ST-246 liquid formulations and methods (2018-11-13),

14. 10045964 - Polymorphic forms of ST-246 and methods of preparation (2018-08-14),

15. 10045963 - Amorphous Tecovirimat preparation (2018-08-14),

SIGA Technologies Inc. is a biotechnology company that specializes in the development and commercialization of pharmaceutical solutions for infectious diseases. They focus on providing innovative antiviral drugs to combat serious viral threats such as smallpox, Ebola, and Lassa fever. With a dedication to improving global public health, SIGA Technologies works closely with government agencies, international organizations, and research partners to enhance preparedness and response to infectious diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

57 Patents

#5 in Corvallis, OR

#74 in Oregon

#6,042 in US

#12,168 in the World

Corvallis, OR, United States of America

Siga Technologies Inc.

Forward Citations = 244

36 inventors:

Dennis E Hruby (43 out of 52 patents)

Dongcheng Dai (33 out of 50 patents)

Tove C Bolken (20 out of 24 patents)

4. Shanthakumar R Tyavanagimatt (19 out of 19 patents)

5. Sean M Amberg (13 out of 19 patents)

Please report any incorrect information to support@idiyas.com

Loading…